Global Oral OTC Analgesics Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 110

Report ID: 9533

The global Oral OTC Analgesics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral OTC Analgesics market based on company, product type, end user and key regions.

This report studies the global market size of Oral OTC Analgesics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral OTC Analgesics in these regions.
This research report categorizes the global Oral OTC Analgesics market by top players/brands, region, type and end user. This report also studies the global Oral OTC Analgesics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Bayer
Novartis
Johnson & Johnson
GlaxoSmithKline
Sanofi
Reckitt Benckiser
Takeda Pharmaceutical Company
Sun Pharmaceutical Industries

Market size by Product
Acetaminophen (TYLENOL)
Salicylates
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Market size by End User
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oral OTC Analgesics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oral OTC Analgesics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oral OTC Analgesics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oral OTC Analgesics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oral OTC Analgesics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral OTC Analgesics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Oral OTC Analgesics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oral OTC Analgesics Market Size Growth Rate by Product
1.4.2 Acetaminophen (TYLENOL)
1.4.3 Salicylates
1.4.4 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
1.5 Market by End User
1.5.1 Global Oral OTC Analgesics Market Size Growth Rate by End User
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Oral OTC Analgesics Market Size
2.1.1 Global Oral OTC Analgesics Revenue 2014-2025
2.1.2 Global Oral OTC Analgesics Sales 2014-2025
2.2 Oral OTC Analgesics Growth Rate by Regions
2.2.1 Global Oral OTC Analgesics Sales by Regions
2.2.2 Global Oral OTC Analgesics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Oral OTC Analgesics Sales by Manufacturers
3.1.1 Oral OTC Analgesics Sales by Manufacturers
3.1.2 Oral OTC Analgesics Sales Market Share by Manufacturers
3.1.3 Global Oral OTC Analgesics Market Concentration Ratio (CR5 and HHI)
3.2 Oral OTC Analgesics Revenue by Manufacturers
3.2.1 Oral OTC Analgesics Revenue by Manufacturers (2014-2019)
3.2.2 Oral OTC Analgesics Revenue Share by Manufacturers (2014-2019)
3.3 Oral OTC Analgesics Price by Manufacturers
3.4 Oral OTC Analgesics Manufacturing Base Distribution, Product Types
3.4.1 Oral OTC Analgesics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral OTC Analgesics Product Type
3.4.3 Date of International Manufacturers Enter into Oral OTC Analgesics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Oral OTC Analgesics Sales by Product
4.2 Global Oral OTC Analgesics Revenue by Product
4.3 Oral OTC Analgesics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Oral OTC Analgesics Breakdown Data by End User

6 North America
6.1 North America Oral OTC Analgesics by Countries
6.1.1 North America Oral OTC Analgesics Sales by Countries
6.1.2 North America Oral OTC Analgesics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Oral OTC Analgesics by Product
6.3 North America Oral OTC Analgesics by End User

7 Europe
7.1 Europe Oral OTC Analgesics by Countries
7.1.1 Europe Oral OTC Analgesics Sales by Countries
7.1.2 Europe Oral OTC Analgesics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral OTC Analgesics by Product
7.3 Europe Oral OTC Analgesics by End User

8 Asia Pacific
8.1 Asia Pacific Oral OTC Analgesics by Countries
8.1.1 Asia Pacific Oral OTC Analgesics Sales by Countries
8.1.2 Asia Pacific Oral OTC Analgesics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Oral OTC Analgesics by Product
8.3 Asia Pacific Oral OTC Analgesics by End User

9 Central & South America
9.1 Central & South America Oral OTC Analgesics by Countries
9.1.1 Central & South America Oral OTC Analgesics Sales by Countries
9.1.2 Central & South America Oral OTC Analgesics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Oral OTC Analgesics by Product
9.3 Central & South America Oral OTC Analgesics by End User

10 Middle East and Africa
10.1 Middle East and Africa Oral OTC Analgesics by Countries
10.1.1 Middle East and Africa Oral OTC Analgesics Sales by Countries
10.1.2 Middle East and Africa Oral OTC Analgesics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Oral OTC Analgesics by Product
10.3 Middle East and Africa Oral OTC Analgesics by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Oral OTC Analgesics Products Offered
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Company Business Overview
11.2.3 Bayer Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bayer Oral OTC Analgesics Products Offered
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Oral OTC Analgesics Products Offered
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Business Overview
11.4.3 Johnson & Johnson Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Johnson & Johnson Oral OTC Analgesics Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Oral OTC Analgesics Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sanofi Oral OTC Analgesics Products Offered
11.6.5 Sanofi Recent Development
11.7 Reckitt Benckiser
11.7.1 Reckitt Benckiser Company Details
11.7.2 Company Business Overview
11.7.3 Reckitt Benckiser Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Reckitt Benckiser Oral OTC Analgesics Products Offered
11.7.5 Reckitt Benckiser Recent Development
11.8 Takeda Pharmaceutical Company
11.8.1 Takeda Pharmaceutical Company Company Details
11.8.2 Company Business Overview
11.8.3 Takeda Pharmaceutical Company Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Takeda Pharmaceutical Company Oral OTC Analgesics Products Offered
11.8.5 Takeda Pharmaceutical Company Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Company Details
11.9.2 Company Business Overview
11.9.3 Sun Pharmaceutical Industries Oral OTC Analgesics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sun Pharmaceutical Industries Oral OTC Analgesics Products Offered
11.9.5 Sun Pharmaceutical Industries Recent Development

12 Future Forecast
12.1 Oral OTC Analgesics Market Forecast by Regions
12.1.1 Global Oral OTC Analgesics Sales Forecast by Regions 2019-2025
12.1.2 Global Oral OTC Analgesics Revenue Forecast by Regions 2019-2025
12.2 Oral OTC Analgesics Market Forecast by Product
12.2.1 Global Oral OTC Analgesics Sales Forecast by Product 2019-2025
12.2.2 Global Oral OTC Analgesics Revenue Forecast by Product 2019-2025
12.3 Oral OTC Analgesics Market Forecast by End User
12.4 North America Oral OTC Analgesics Forecast
12.5 Europe Oral OTC Analgesics Forecast
12.6 Asia Pacific Oral OTC Analgesics Forecast
12.7 Central & South America Oral OTC Analgesics Forecast
12.8 Middle East and Africa Oral OTC Analgesics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral OTC Analgesics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer